Market by Drugs & Devices and Geography | Forecast 2019- 2027
The Asia-Pacific ophthalmology drugs and devices market is expected to make progressive growth at a CAGR of 6.41% in terms of revenue throughout the estimated period 2019-2027.
The countries that have been studied in the report on the Asia-Pacific’s ophthalmology drugs and devices market are:
• India
• China
• Japan
• South Korea
• Australia & New Zealand
• ASEAN Countries
• Rest of APAC
Report scope can be customized per your requirements. Request For Customization
The ophthalmology drugs and devices market in India is primarily driven by ongoing government researches related to eye care and the rising healthcare expenditure. According to the All India Institute of Medical Sciences (India), the government is continuously involved in various research activities, mainly on eye care researches and projects. For instance, in 2017, the association was involved in various studies named “Patterns and Pathways of Care Seeking for Common Ocular and Cataract Morbidities and Diabetic Retinopathy” to study the pattern of prevalence of these diseases. Further, due to these ongoing research activities on eye care, the need for ophthalmology drugs and devices would rise, which positively influences the growth of the ophthalmology drugs and devices market in India.
The key drivers for the ophthalmology drugs and devices market in South Korea are the growing number of cataract surgeries in the country and the rising medical tourism. As per the National Health Insurance Service, in 2016, around 360,000 people underwent cataract surgery in South Korea, accounting for the most performed surgery covered by insurance, that may raise the demand for the intraocular lens, which directly influences the growth of the ophthalmology drugs and devices market in this country. Furthermore, the rising medical tourism in the country also drives the ophthalmology drugs and devices market. As per the China CN Organization, South Korea is the most favoured destination for medical procedures and foreign tourists coming for medical tourism in South Korea from 188 countries. In 2013, the country received about 399,000 medical tourists in 2013 and about 598,000 medical tourists in 2015. This figure may reach 998,000 by 2020, according to recent estimates, which is expected to boost the growth of the ophthalmology drugs and devices market in South Korea during the forecast period.
Santen Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company that develops, manufactures and commercializes prescription ophthalmic pharmaceutical products for the enhancement and protection of eyesight and health, primarily in Japan as well as internationally. The company is specialized in the ophthalmic field and has a dominant position in Japan's prescription ophthalmic pharmaceutical market. At the end of 31st March 2017, the company earned an overall revenue of $1.89 billion, in which, its prescription ophthalmic pharmaceutical products generated revenue of $1.23 billion.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1.
ASIA-PACIFIC OPHTHALMOLOGY DRUGS AND DEVICES MARKET - SUMMARY
2.
INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. PORTER’S FIVE FORCES ANALYSIS
2.2.1.
BARGAINING POWER OF BUYERS
2.2.2.
BARGAINING POWER OF SUPPLIER
2.2.3.
THREATS OF NEW ENTRANTS
2.2.4.
THREATS OF SUBSTITUTES
2.2.5.
COMPETITIVE RIVALRY
2.3. STRATEGIC OUTLOOK
2.4. KEY INSIGHT
2.5. VALUE CHAIN OUTLOOK
2.6. KEY BUYING STANDARDS
2.7. INVESTMENT OUTLOOK
2.8. SUPPLY CHAIN OUTLOOK
2.9. REGULATORY FRAMEWORK
2.10.
MARKET DRIVERS
2.10.1.
INCREASING OPHTHALMIC DISORDERS DUE TO HIGH BLOOD SUGAR
2.10.2.
UPSURGE IN HEALTHCARE SPENDING
2.10.3.
TECHNOLOGICAL ADVANCEMENT
2.11.
MARKET RESTRAINTS
2.11.1.
EXPIRATIONS OF BRAND PATENTS HAVE AFFECTED THE PHARMACEUTICAL INDUSTRY
2.11.2.
LOW COGNIZANCE RELATED TO OPHTHALMIC DRUGS
2.11.3.
DRUG APPROVALS DELAY AND NUMBER OF DRUGS IN THE PIPELINE
2.12.
MARKET OPPORTUNITIES
2.12.1.
DEMAND FOR PHACOEMULSIFICATION DEVICES AND INTRAOCULAR LENSES IS
INCREASING
2.13.
MARKET CHALLENGES
2.13.1.
DIFFICULTIES ASSOCIATED WITH THE CONDUCT OF OCULAR DISEASES
3.
OPHTHALMOLOGY DRUGS AND DEVICES MARKET OUTLOOK - BY DRUGS AND DEVICES
3.1. DEVICES
3.1.1.
DIAGNOSTIC & MONITORING EQUIPMENT
3.1.1.1.
OPTICAL COHERENCE TOMOGRAPHY
3.1.1.2.
OPHTHALMIC ULTRASOUND IMAGING SYSTEMS
3.1.1.3.
FUNDUS CAMERA MARKET
3.1.1.4.
OPHTHALMOSCOPES
3.1.1.5.
RETINOSCOPE
3.1.1.6.
PACHYMETER
3.1.1.7.
WAVEFRONT ABERROMETERS
3.1.1.8.
PERIMETERS/VISUAL FIELD ANALYZER
3.1.1.9.
AUTOREFRACTORS/PHOROPTER
3.1.1.10.
SPECULAR MICROSCOPE
3.1.1.11.
CORNEAL TOPOGRAPHERS
3.1.1.12.
OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET
3.1.2.
SURGERY DEVICES
3.1.2.1.
CATARACT SURGERY DEVICES
3.1.2.2.
GLAUCOMA SURGERY DEVICES
3.1.2.3.
REFRACTIVE SURGERY DEVICES
3.1.2.4.
VITREORETINAL SURGERY DEVICES
3.1.3.
VISION CARE
3.2. DRUGS
3.2.1.
GLAUCOMA DRUG
3.2.2.
RETINAL DISORDER DRUG
3.2.3.
DRY EYE DRUG
3.2.4.
ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG
3.2.5.
DRUGS BY USE OF PRESERVATION
3.2.5.1.
PRESERVED DRUGS
3.2.5.2.
PRESERVATIVE-FREE DRUGS
4.
OPHTHALMOLOGY DRUGS AND DEVICES MARKET - REGIONAL OUTLOOK
4.1.1.
INDIA
4.1.2.
CHINA
4.1.3.
JAPAN
4.1.4.
SOUTH KOREA
4.1.5.
AUSTRALIA & NEW ZEALAND
4.1.6.
ASEAN COUNTRIES
4.1.7.
REST OF APAC
5.
COMPETITIVE LANDSCAPE
5.1. ALLERGAN, INC.
5.2. BAYER
5.3. CARL ZEISS AG
5.4. ESSILOR INTERNATIONAL S.A.
5.5. GLAXOSMITHKLINE
5.6. JOHNSON & JOHNSON, INC.
5.7. NOVARTIS INTERNATIONAL AG
5.8. PFIZER
5.9. ROCHE HOLDING AG
5.10.
SANTEN PHARMACEUTICAL CO., LTD.
6.
METHODOLOGY AND SCOPE
6.1. RESEARCH SCOPE
6.2. SOURCES OF DATA
6.3. RESEARCH METHODOLOGY
TABLE 1 ASIA-PACIFIC OPHTHALMOLOGY
DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 2 COMMON CAUSES OF
LOSS OF VISION IN THE ELDERLY
TABLE 3 SELECTED LIST OF
GLAUCOMA DRUGS IN LATE-STAGE CLINICAL TRIALS
TABLE 4 ASIA-PACIFIC OPHTHALMOLOGY
DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)
TABLE 5 ASIA-PACIFIC DEVICES
MARKET IN DIAGNOSTIC & MONITORING EQUIPMENT BY TYPES 2019-2027 ($ MILLION)
TABLE 6 ASIA-PACIFIC DEVICES
MARKET IN SURGERY DEVICE BY TYPES 2019-2027 ($ MILLION)
TABLE 7 ASIA-PACIFIC DRUGS
AND DEVICES MARKET IN DRUGS BY TYPES 2019-2027 ($ MILLION)
TABLE 8 ASIA-PACIFIC OPHTHALMOLOGY
DRUGS AND DEVICES MARKET BY COUNTRIES 2019-2027 ($ MILLION)
FIGURE 1
ASIA-PACIFIC OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027
FIGURE 2 ASIA-PACIFIC
DRUGS AND DEVICES MARKET IN DEVICES 2019-2027 ($ MILLION)
FIGURE 3 ASIA-PACIFIC
DEVICES MARKET IN DIAGNOSTIC & MONITORING EQUIPMENT 2019-2027 ($ MILLION)
FIGURE 4 ASIA-PACIFIC
DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPTICAL COHERENCE TOMOGRAPHY
2019-2027 ($ MILLION)
FIGURE 5 ASIA-PACIFIC
DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPHTHALMIC ULTRASOUND IMAGING
SYSTEMS 2019-2027 ($ MILLION)
FIGURE 6 ASIA-PACIFIC
DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN FUNDUS CAMERA MARKET 2019-2027
($ MILLION)
FIGURE 7 ASIA-PACIFIC
DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPHTHALMOSCOPES 2019-2027 ($
MILLION)
FIGURE 8 ASIA-PACIFIC
DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN RETINOSCOPE 2019-2027 ($
MILLION)
FIGURE 9 ASIA-PACIFIC
DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN PACHYMETER 2019-2027 ($
MILLION)
FIGURE 10 ASIA-PACIFIC
DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN WAVEFRONT ABERROMETERS
2019-2027 ($ MILLION)
FIGURE 11
ASIA-PACIFIC DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN PERIMETERS/VISUAL
FIELD ANALYZER 2019-2027 ($ MILLION)
FIGURE 12 ASIA-PACIFIC
DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN AUTOREFRACTORS/PHOROPTER
2019-2027 ($ MILLION)
FIGURE 13 ASIA-PACIFIC
DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN SPECULAR MICROSCOPE 2019-2027
($ MILLION)
FIGURE 14 ASIA-PACIFIC
DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN CORNEAL TOPOGRAPHERS 2019-2027
($ MILLION)
FIGURE 15 ASIA-PACIFIC
DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OTHER DIAGNOSTIC &
MONITORING EQUIPMENT MARKET 2019-2027 ($ MILLION)
FIGURE 16 ASIA-PACIFIC
DEVICES MARKET IN SURGERY DEVICE 2019-2027 ($ MILLION)
FIGURE 17 ASIA-PACIFIC
SURGERY DEVICES MARKET IN CATARACT SURGERY DEVICES 2019-2027 ($ MILLION)
FIGURE 18 ASIA-PACIFIC
SURGERY DEVICES MARKET IN GLAUCOMA SURGERY DEVICES 2019-2027 ($ MILLION)
FIGURE 19 ASIA-PACIFIC
SURGERY DEVICES MARKET IN REFRACTIVE SURGERY DEVICES 2019-2027 ($ MILLION)
FIGURE 20 ASIA-PACIFIC
SURGERY DEVICES MARKET IN VITREORETINAL SURGERY DEVICES 2019-2027 ($ MILLION)
FIGURE 21 ASIA-PACIFIC
DEVICES MARKET IN VISION CARE MARKET 2019-2027 ($ MILLION)
FIGURE 22 ASIA-PACIFIC
DRUGS AND DEVICES MARKET IN DRUGS 2019-2027 ($ MILLION)
FIGURE 23 ASIA-PACIFIC
DRUGS MARKET IN GLAUCOMA DRUG 2019-2027 ($ MILLION)
FIGURE 24 ASIA-PACIFIC
DRUGS MARKET IN RETINAL DISORDER DRUG 2019-2027 ($ MILLION)
FIGURE 25 ASIA-PACIFIC
DRUGS MARKET IN DRY EYE DRUG 2019-2027 ($ MILLION)
FIGURE 26 ASIA-PACIFIC
DRUGS MARKET IN ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG
2019-2027 ($ MILLION)
FIGURE 27 ASIA-PACIFIC
DRUGS BY USE OF PRESERVATION IN PRESERVED DRUGS 2019-2027 ($ MILLION)
FIGURE 28 ASIA-PACIFIC
DRUGS BY USE OF PRESERVATION IN PRESERVATIVE-FREE DRUGS 2019-2027 ($ MILLION)
FIGURE 29 ASIA-PACIFIC
PRESERVATIVE-FREE DRUGS MARKET IN SINGLE-DOSE 2019-2027 ($ MILLION)
FIGURE 30 ASIA-PACIFIC
PRESERVATIVE-FREE DRUGS MARKET IN MULTI-DOSE 2019-2027 ($ MILLION)
FIGURE 31 ASIA-PACIFIC
OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 32 INDIA
OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 33 CHINA
OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 34 JAPAN
OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 35 SOUTH
KOREA OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 36 AUSTRALIA
& NEW ZEALAND OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 37 ASEAN
COUNTRIES OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 38 REST OF APAC OPHTHALMOLOGY DRUGS AND DEVICES
MARKET 2019-2027 ($ MILLION)